Debra Odink is CTO at Anthera Pharmaceuticals Inc (ANTH). They have made 1 open-market trade across 1 company since 2010, most recently 2015-10-12.
CIK 0001281719
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $4K since 2010, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ANTH | 7,896 | — |
Shares reported on the most recent Form 4, priced at the 2015-10-13 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANTH | SELL · 10b5-1 | 2015-10-12 | 2015-10-13 | $6.15 | $7K | N/A | N/A | N/A |
| ANTH | SELL · 10b5-1 | 2012-03-01 | 2012-03-05 | $6.57 | $13K | N/A | N/A | N/A |
| ANTH | SELL · 10b5-1 | 2012-02-01 | 2012-02-03 | $7.67 | $15K | N/A | N/A | N/A |
| ANTH | SELL · 10b5-1 | 2012-01-10 | 2012-01-12 | $6.51 | $5K | N/A | N/A | N/A |
| ANTH | SELL · 10b5-1 | 2012-01-06 | 2012-01-10 | $6.50 | $8K | N/A | N/A | N/A |
| ANTH | BUY | 2010-09-24 | 2010-09-24 | $4.20 | $4K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.